Improve definition of titanium tandems in MR-guided high dose rate brachytherapy for cervical cancer using proton density weighted MRI by Hu, Yanle et al.




Improve definition of titanium tandems in MR-
guided high dose rate brachytherapy for cervical
cancer using proton density weighted MRI
Yanle Hu
Washington University School of Medicine in St. Louis
Jacqueline Esthappan
Washington University School of Medicine in St. Louis
Sasa Mutic
Washington University School of Medicine in St. Louis
Susan Richardson
Washington University School of Medicine in St. Louis
Hiram A. Gay
Washington University School of Medicine in St. Louis
See next page for additional authors
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Hu, Yanle; Esthappan, Jacqueline; Mutic, Sasa; Richardson, Susan; Gay, Hiram A.; Schwarz, Julie K.; and Grigsby, Perry W., ,"Improve
definition of titanium tandems in MR-guided high dose rate brachytherapy for cervical cancer using proton density weighted MRI."
Radiation Oncology.8,. 16. (2013).
http://digitalcommons.wustl.edu/open_access_pubs/1276
Authors
Yanle Hu, Jacqueline Esthappan, Sasa Mutic, Susan Richardson, Hiram A. Gay, Julie K. Schwarz, and Perry W.
Grigsby
This open access publication is available at Digital Commons@Becker: http://digitalcommons.wustl.edu/open_access_pubs/1276
RESEARCH Open Access
Improve definition of titanium tandems in MR-
guided high dose rate brachytherapy for cervical
cancer using proton density weighted MRI
Yanle Hu*, Jacqueline Esthappan, Sasa Mutic, Susan Richardson, Hiram A Gay, Julie K Schwarz and Perry W Grigsby
Abstract
Background: For cervical cancer patients treated with MR-guided high dose rate brachytherapy, the accuracy of
radiation delivery depends on accurate localization of both tumors and the applicator, e.g. tandem and ovoid.
Standard T2-weighted (T2W) MRI has good tumor-tissue contrast. However, it suffers from poor uterus-tandem
contrast, which makes the tandem delineation very challenging. In this study, we evaluated the possibility of using
proton density weighted (PDW) MRI to improve the definition of titanium tandems.
Methods: Both T2W and PDW MRI images were obtained from each cervical cancer patient. Imaging parameters
were kept the same between the T2W and PDW sequences for each patient except the echo time (90 ms for T2W
and 5.5 ms for PDW) and the slice thickness (0.5 cm for T2W and 0.25 cm for PDW). Uterus-tandem contrast was
calculated by the equation C = (Su-St)/Su, where Su and St represented the average signal in the uterus and the
tandem, respectively. The diameter of the tandem was measured 1.5 cm away from the tip of the tandem. The
tandem was segmented by the histogram thresholding technique.
Results: PDW MRI could significantly improve the uterus-tandem contrast compared to T2W MRI (0.42±0.24 for
T2W MRI, 0.77±0.14 for PDW MRI, p=0.0002). The average difference between the measured and physical diameters
of the tandem was reduced from 0.20±0.15 cm by using T2W MRI to 0.10±0.11 cm by using PDW MRI (p=0.0003).
The tandem segmented from the PDW image looked more uniform and complete compared to that from the T2W
image.
Conclusions: Compared to the standard T2W MRI, PDW MRI has better uterus-tandem contrast. The information
provided by PDW MRI is complementary to those provided by T2W MRI. Therefore, we recommend adding PDW
MRI to the simulation protocol to assist tandem delineation process for cervical cancer patients.
Keywords: Cervical cancer, MRI, HDR Brachytherapy, T2 weighting, Proton density weighting
Background
Cervical cancer ranks the third in the United States
based on the average number of life years lost due to
cancer [1]. It continues to be a significant problem in
the United States and worldwide. In our clinic, cervical
cancer patients are treated with daily external beam
radiation therapy and weekly high dose rate (HDR)
brachytherapy [2-4]. In HDR brachytherapy, radiation is
delivered through a “tandem and ovoid” applicator.
Knowledge of precise locations of both the tumor and
the applicator relative to internal anatomy is essential to
ensure radiation delivery accuracy, which may turn into
improved local control and reduced morbidity.
Imaging modalities used for treatment planning for
cervical cancer patients include computed tomography
(CT) [5,6] and magnetic resonance imaging (MRI) [7-12].
Currently, CT is considered as the standard imaging
modality for radiotherapy treatment planning for cervical
cancer. It is fast and has a good spatial resolution. How-
ever, CT has poor soft tissue contrast, which makes it very
challenging to delineate the tumor from surrounding
tissues. MRI has great soft tissue contrast. It offers a
variety of sequences such as T2 weighted (T2W) MRI and
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diffusion weighted imaging (DWI) to enhance the contrast
between tumors and surrounding tissues. With better
tumor-tissue contrast, it is possible to customize the treat-
ment for each fraction based on the size and location of
the cervical tumor. In addition, MRI does not involve any
ionizing radiation and won’t add radiation dose to
patients. Those advantages make MRI highly desirable in
radiation oncology, especially in pelvic area such as
cervical cancer.
The “tandem and ovoid” applicator used to treat
cervical cancer is made of titanium. It is light, strong
and compatible with the MRI imaging modality. How-
ever, it does introduce artifact to MRI images. Titanium
is paramagnetic whereas soft tissues are in general
slightly diamagnetic. When titanium tandems are placed
in cervical cancer patients treated with HDR brachytherapy,
the susceptibility difference between the titanium tandems
and surrounding soft tissues can result in local magnetic
field gradients along the interface, causing signal loss and
geometric distortion around titanium tandems. Since
titanium doesn’t contain hydrogen atoms, tandems are
dark in MRI images. In standard T2W MRI images, the
uterus signal is typically very low due to the use of long
echo time (TE). As a result, the contrast between the
uterus and the tandem is pretty low, making the tandem
delineation challenging. Using titanium applicators in
MR-guided brachytherapy has been investigated in several
studies [13-16]. Haack et al. reported that albeit very chal-
lenging, it was possible to assess titanium applicator
geometry on T1 weighted (T1W) and T2W MRI images
[14]. Wills et al. showed the feasibility of reconstructing
titanium applicator using images from 0.35T open MRI
scanner [15].
Reducing metal artifacts has been discussed substan-
tially in MRI field for a long time and several sequences
have been developed to address this issue [17-20]. How-
ever, those techniques remain mostly in research studies.
They have not been widely adopted in clinical applica-
tions, primarily because 1) they are not very robust, and
2) most existing clinical MRI scanners don’t have the
capability to incorporate work-in-progress sequences.
Therefore, establishing new methods to reduce metal
artifacts by exploiting the available product sequences
and optimizing imaging parameters can be more benefi-
cial to clinical work.
For MR-guided HDR brachytherapy for cervical
cancer, the most commonly used sequence is T2W MRI
because it can provide good tumor-tissue contrast [21].
However, using long TE in T2W MRI not only makes it
very susceptible to susceptibility gradients caused by
metal implants, but also significantly reduces the uterus
signal and thus the contrast between the uterus and the
titanium tandem. As a result, tandem delineation
becomes a challenging and time consuming process.
GEC-ESTRO (The Groupe Européen de Curiethérapie -
the European Society for Therapeutic Radiology and
Oncology) recommended that in some situation it can
be can an option to acquire CT images or additional
MRI image set to assist tandem delineation and stream-
line the whole process. Since CT scans involves un-
wanted radiation, acquiring another MRI image set is
more preferable. Among available MRI sequences, T1W
MRI is one option. Using T1W MRI to assist tandem
delineation has been discussed previously in several
studies [14,16,22]. In this study, we focused our effort on
another commonly available MRI sequence - proton
density weighted (PDW) MRI, which might be used to
assist tandem delineation but hadn’t received enough
discussion yet.
Compared to T2W MRI, PDW MRI uses a very short
TE and a very long repetition time (TR) [23] which
makes it highly SNR (signal to noise ratio) efficient and
also less sensitive to susceptibility effect. High SNR effi-
ciency can enhance the contrast between the uterus and
the titanium tandem, making tandem delineation easier.
In addition, it is possible to trade SNR for thinner slice,
which helps mitigate the signal loss around titanium tan-
dems. PDW MRI is available on almost all commercial
MRI scanners, just like T2W MRI. Therefore, improved
uterus-tandem contrast and reduced tandem delineation
effort can be achieved on any existing MRI scanner.
Methods
To show the effectiveness of using PDW MRI in assist-
ing the delineation of the “tandem and ovoid” applicator,
we retrospectively reviewed MRI images from cervical
cancer patients who were treated with MR-guided HDR
brachytherapy in our clinic and had both T2W and
PDW images acquired. This study was approved by the
Human Research Protection Office and the Protocol
Review and Monitoring Committee of the Washington
University School of Medicine. We retrospectively
reviewed MRI images from ten patients treated from 11/
2010 to 01/2011. The average patient age was 52.8±10.4
years.
After the placement of the applicator, cervical cancer
patients were taken to the MRI suite for simulation. All
MRI images were acquired on a 1.5T MRI scanner
(Intera, Philips Medical Systems, Best, Netherlands). The
body coil was used to transmit the Radiofrequency excita-
tion pulse and a 4-channel pelvic coil was used to receive
the signal. The imaging protocol started with a 3-plane
localizer, followed by a reference scan to determine the
coil sensitivity. After that, fat-saturated T2W images in
axial plane were acquired. This image set was used to
guide the subsequent para-sagittal images so that the
tandem was parallel to the acquired para-sagittal plane
and could be seen clearly as a whole in para-sagittal slices.
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T2W and PDW images in the para-sagittal plane were
acquired subsequently. The Turbo spin echo (TSE)
imaging technique was used in both sequences. Imaging
parameters for T2W MRI are listed below. Slice thickness
was 5mm, gap between adjacent slices was 0mm,
in-plane resolution was 1mm×1mm and TE was 90ms.
The field of view (FOV) and the number of slices were
determined according to patient’s anatomy. In PDW MRI,
in-plane resolution was 1mm×1mm and TE was 5.5ms.
Since PDW MRI has high SNR efficiency, we were able to
reduce slice thickness to 2.5 mm to decrease sequence’s
sensitivity to susceptibility effect caused by metal implants
but still maintain a good SNR for treatment planning. The
number of slices and the in-plane FOV were kept the
same as those used in T2W MRI. In slice-selected direc-
tion, PDW MRI had only half of the coverage compared
to that provided by T2W MRI. The reduced coverage of
PDW MRI in slice-select direction was justified as the
main purpose of PDW MRI was to assist tandem delinea-
tion. The range of TR for both sequences was set between
3000ms and 6000ms, with the exact value determined by
the scanner after optimization. After all scans were
finished, images were sent to BrachyVision (Varian Medical
Systems) for treatment planning and to the corresponding
author’s workstation after de-identification for further
image analysis.
During the entire treatment, each cervical cancer
patient received 6 HDR brachytherapy procedures, or
fractions. Since the improvement in uterus-tandem
contrast is similar in all fractions, only images from the
first fraction were used in this study. The comparison of
T2W and PDW MRI were performed in both qualitative
and quantitative methods.
Qualitatively, we compared T2W and PDW MRI
images to determine which image sets had a better def-
inition of the tandem. Signal profiles along a line which
was perpendicular to the titanium tandem were obtained
for both image sets. In addition, we segmented the tan-
dem from surrounding tissues based on the histogram
thresholding approach [24] and compared the segmen-
ted images obtained from T2W and PDW MRI images.
In the histogram thresholding approach, one slice
containing the majority portion of the tandem was
selected from each image sets. A small region of interest
(ROI) was placed around the tip of the tandem. Only
two structures were included in the ROI: the tandem
and the uterus. Histograms of the signal in the selected
ROI were plotted for both image sets. Peaks in histo-
grams corresponded to either the uterus or the tandem.
Histograms were examined to see if peaks corresponding
to the tandem and the uterus could be easily separated.
A threshold was determined based on each histogram
and was used to segment the corresponding MRI image.
Voxels with signal intensity above the threshold
(presumably the uterus) were set to 0. The rest of voxels
(presumably the tandem) were set to 1. Structures other
than the uterus and tandem are of little concerns in this
segmentation process. The segmented images were visu-
ally inspected for the effectiveness of the segmentation.
Quantitatively, we compared the measured diameter of
the tandem. The measurement was performed by an
experienced medical physicist. On T2W images, the
diameter of the tandem varies with the distance from
the tip of the tandem. In addition, adjusting the window-
ing level also changes the measured diameter. To
standardize the procedure of the measurement and
reduce the corresponding bias as much as possible, the
following two steps were performed during the measure-
ment. First, the window level was determined based on
the plastic ovoid because it has minimal geometric
distortion in spin echo sequences. For each image, the
window level was set so that the diameter of the ovoid
was within 0.1 cm of the actual diameter. Second, the
diameter of the tandem was measured at 1.5 cm from
the tip of the tandem. The tip of the tandem was deter-
mined based on the PDW MRI image due to its better
image quality. This measurement location was mapped
to the co-registered T2W MRI image to ensure that the
diameter was measured at the same location for both
T2W and PDW images. The measured diameters of the
tandem from MRI images were compared to the physical
diameter, which was 0.345 cm determined by the caliper.
The contrast between the uterus and the tandem was
also quantitatively determined for each patient and each
image set. Again, the measurement was performed at
the location which was 1.5 cm from the tip of the
tandem. At this location, we drew a line which was per-
pendicular to the tandem. Along this line, two ROIs
were placed. One was at the middle of the tandem and
the other was 1.0 cm from the tandem in the uterus area.
The size of the ROI within the uterus was 3 mm×3mm,
whereas the size of the ROI within the tandem was
1.5 mm×1.5 mm due to the small diameter of the
tandem. The contrast can be determined by equation
C = (Su − St)/Su, where Su is the average signal in the
uterus and St is the average signal in the tandem.
Results
Figure 1 shows the comparison of T2W and PDW MRI
images from a representative subject in localizing the
tumor and the applicator. Qualitatively, the T2W image
has a better tumor-tissue contrast. However, the low
signal in the uterus reduces the contrast between the
uterus and the tandem. In addition, the diameter of the
tandem becomes wider towards the tip of the tandem.
Therefore, T2W MRI can be a good candidate for tumor
delineation but not a very good choice for defining the
tandem. The PDW image, however, has more uniform
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and higher signal in the uterus even at 2.5 mm slice
thickness, which makes it a lot easier to segment the
tandem from the uterus. Figure 2 shows the comparison
of profiles along the line perpendicular to the tandem.
The location of the line is shown in Figure 1 around the
top portion of the tandem. From Figure 2, it can be seen
that the tandem looks narrower and sharper on PDW
MRI than on T2W MRI. Table 1 lists the average signal
in the uterus and the tandem. The uterus-tandem con-
trast was calculated for both image sets for all patients.
The average uterus-tandem contrast from all patients
was 0.42±0.24 for T2W MRI and 0.77±0.14 for PDW
MRI. The improvement was statistically significant
(p=0.0002).
To segment the tandem from the uterus using the
histogram thresholding approach, a ROI was placed
around the tip of the tandem. The selection of the ROI
followed the steps described in the “Methods” section.
Histograms of signal intensity in the ROI from T2W and
PDW images are shown in Figure 3. Two peaks in the
histograms corresponded to the uterus (the right peak)
and the tandem (the left peak), respectively. For T2W
MRI shown in Figure 3a, the two peaks overlapped with
each other. Selecting a threshold to separate the two
peaks was very challenge. In this case, a threshold of 70
was selected to segment the image. For PDW MRI
shown in Figure 3b, the two peaks were clearly separ-
able by using a threshold of 90. The segmented images
using the thresholds determined by the histogram
thresholding approach are shown in Figure 4. The tan-
dem segmented from the PDW image looked more
Figure 1 Comparison of (a) T2W and (b) PDW MRI images for localizing tumors and the applicator. White lines across the tandem on
both images were added during the post processing to show the location of signal profiles plotted in Figure 2.
Figure 2 Profiles across the tandem along the white lines
shown in Figure 1. The PDW image show a uniform signal in the
uterus, and a sharper and narrower tandem in the middle compared
to the T2W image.
Table 1 Measured uterus, tandem signal as well as the
uterus-tandem contrast
Patient T2W PDW
Su St Contrast Su St Contrast
1 134 66 0.51 217 31 0.86
2 126 89 0.29 190 28 0.85
3 95 88 0.07 189 55 0.71
4 133 49 0.63 189 40 0.79
5 248 128 0.48 191 60 0.69
6 148 87 0.41 213 38 0.82
7 108 42 0.61 225 14 0.94
8 85 82 0.04 177 100 0.44
9 172 37 0.78 210 41 0.80
10 96 64 0.33 123 28 0.77
AVE±STD 0.42±0.24 0.77±0.14
Paired student t-test 0.0002
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uniform and complete compared to that from the T2W
image.
Table 2 lists the measured diameters of the tandem from
the T2W and PDW images, differences between the mea-
sured diameter and the physical diameter (0.345 cm) of
the tandem, the curvature of the tandem, and the physical
diameter of the ovoid for each patient. The average mea-
sured diameters of the tandem from the T2W and PDW
images were 0.54±0.15 cm and 0.45±0.11 cm, respectively.
The average differences, or errors, between measured and
physical diameters of the tandem were 0.20±0.15 cm for
T2W MRI and 0.10±0.11cm for PDW MRI. The
improvement by using PDW MRI was statistically signifi-
cant (p=0.0003).
Discussion
The feasibility of using PDW MRI to assist tandem de-
lineation for cervical cancer patients treated with HDR
brachytherapy was proved in this work. It was shown
that PDW MRI had a better uterus-tandem contrast
compared to T2W MRI. Qualitatively, the tandem had a
better and more uniform shape on PDW MRI. Quantita-
tively, the difference between measured and physical
Figure 3 Comparison of histograms of signal intensity between (a) T2W and (b) PDW MRI. Histograms were obtained based on a small
ROI placed around the tip of the tandem. Two peaks corresponding to the uterus and the tandem were overlapped in the T2W image but
separable in the PDW image.
Figure 4 Comparison of the segmented image using (a) T2W and (b) PDW images. Image segmentation was based on the histogram
thresholding technique. Thresholds were 70 and 90 for T2W and PDW images, respectively. The tandem looked nice and complete in the PDW
image but quite fragmental in the T2W image.
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diameters of the tandem was significantly reduced by
using PDW MRI, confirming PDW MRI had reduced
artifacts.
Although one of the standard methods to reduce geo-
metric distortion and signal dropout is to increase the
bandwidth and/or matrix size, it may not be a practical
solution to improve image quality of T2W MRI and
reduce effort in tandem delineation. In T2W MRI, the
uterus signal is typically very low because of the use of
long TE. The uterus-tandem contrast is barely enough
for the delineation purpose. Increasing the bandwidth
and/or matrix size, however, will significantly reduce the
image SNR and thus the uterus-tandem contrast,
making tandem delineation extremely difficult, if not
impossible at all. PDW MRI uses a very short (5.5 ms vs.
90 ms). Therefore, the uterus signal is much higher in
PDW MRI compared to T2W MRI, which not only
increases the uterus-tandem contrast, but also allows us
to use thinner slices to further reduce the geometric dis-
tortion and signal dropout around the titanium tandem.
T1W MRI utilizes a TE which is comparable to PDW
MRI. When T1W and PDW images are acquired using
the same TE, bandwidth and spatial resolution, the two
image datasets should exhibit similar amount of metal
artifacts. On the other hand, T1W MRI utilizes a
relatively shorter TR compared to PDW MRI, which
makes it less SNR efficient. The long TR used in PDW
MRI allows the magnetization to be fully relaxed before
the next excitation. Therefore, more magnetization will
be available at the beginning of each RF excitation,
resulting in higher signal (or SNR) in PDW MRI. The
SNR advantage of PDW MRI may be traded off for
better spatial resolution, which will further reduce metal
artifacts.
Image fusion between the T2W and PDW images was
accomplished by using the coordinates stored in the
DICOM header. This was warranted in this study
because 1) the tabletop supporting patients did not
move between the T2W and PDW MRI scans, all MRI
images were acquired by changing the imaging hardware
such as gradients; and 2) patients were still under medi-
cation for pain control which made them sleepy and less
likely to move. None of the 10 patients included in this
study showed significant movement between T2W and
PDW MRI. If in future we do observe significant move-
ment between scans, we can implement sophisticated
fusion techniques based on patient’s anatomy to ensure
the accuracy of the quantitative analysis.
The measured diameters from MRI images had a
relatively large variance among patients. The largest
measurement was 0.79 cm in one of the T2W images
whereas the smallest measurement was 0.29 cm in one
of the PDW images. The standard deviations in diameter
measurement were 0.15 cm and 0.11 cm for T2W and
PDW images, respectively. After examining Table 1, we
noticed that there was a good correlation between the
measured diameters from T2W images and PDW
images. Specifically, if the measured diameter from the
T2W image was large, the corresponding measured tan-
dem diameter from the PDW image was also large and
vice versa. In addition, we found that the measured
diameter of the tandem correlated well with the curva-
ture of the tandem. Patients using a tandem with bigger
curvature tended to have a larger measured diameter. If
patients were grouped by the curvature of the tandem, 3
patients had tandem curvature of 30° and 7 patients had
tandem curvature of 45°. For the group with tandem
curvature of 30°, the standard deviation of measured






Measured diameter (cm) Difference from physical diameter (cm)
T2W PDW T2W PDW
1 30° 2.0 0.42 0.37 0.075 0.025
2 30° 2.0 0.32 0.29 −0.025 −0.055
3 30° 2.0 0.35 0.31 0.005 −0.035
4 45° 2.0 0.62 0.53 0.275 0.185
5 45° 1.6 0.49 0.39 0.145 0.045
6 45° 2.5 0.79 0.58 0.445 0.235
7 45° 2.5 0.61 0.53 0.265 0.185
8 45° 1.6 0.62 0.53 0.275 0.185
9 45° 2.5 0.68 0.55 0.335 0.205
10 45° 2.0 0.52 0.39 0.175 0.045
AVE±STD 0.54±0.15 0.45±0.11 0.20±0.15 0.10±0.11
Paired student t-test 0.0003 0.0003
The curvature of the tandem, the physical diameter of the ovoid, the measured diameter of the tandem, as well as the difference between the measured
diameter and the physical diameter (0.345 cm) from the T2W and PDW images for each patient are listed.
Hu et al. Radiation Oncology 2013, 8:16 Page 6 of 8
http://www.ro-journal.com/content/8/1/16
diameters reduced to 0.05 cm by using the T2W images
and to 0.04 cm by using the PDW images. Similarly, for
the group with tandem curvature of 45°, the standard
deviation of measured diameters reduced to 0.10 cm by
using the T2W images and to 0.08 cm by using the
PDW images. We also noticed that some of the mea-
sured diameters were smaller than the physical diameter
of the tandem. This may be explained by the relative
location of the slices to the tandem. If the tandem is
equally distributed into two adjacent para-sagittal slices
along its axis, then each slice contains half of the
tandem. Since the radius of the tandem is smaller than
the slice thickness, for any voxels within the region of
the tandem, it contains both tandem and the uterus.
This partial volume effect may lower the contrast be-
tween the tandem and the uterus, making the measured
diameter of the tandem smaller than its physical diam-
eter. All these observations suggest that the measured
diameter of the tandem is related to the curvature of the
tandem, the location of slices, and the placement of the
receiving coil and the applicator as well. Further investi-
gation is needed and will be conducted in the future to
fully understand the causes.
The focus of this retrospective study was to show the
feasibility of using PDW MRI as an option to assist tan-
dem delineation for cervical cancer patients treated with
HDR brachytherapy. Other options to assist tandem de-
lineation include acquiring additional x-ray images, CT
images, T1W MRI or other MRI image-sets. Evaluating
those options to find the best choice is a very interesting
topic and of great clinical importance. However, it is out
of the scope of this study. Such kind of study will be
planned and performed in the future after being care-
fully designed to minimize the bias in the process of
comparing images from different imaging modalities.
Another interesting project is to compare dwell posi-
tions determined by MR images (T2W, T1W and PDW)
and CT images. In our preliminary study on phantom
[25], we found that mean differences between activated
dwells on MRI vs. CT were approximately 0.1cm or less,
0.2 cm and 0.1 cm in RL (right-left), FH (foot-head), and
AP (anterior-posterior) directions, respectively. Com-
parisons between T2W and PDW MRI showed about
0.1 cm difference in the FH direction and negligible
differences in the other directions. Comparison of dwell
positions using patient image datasets is currently under
investigation.
Conclusions
In this work, it was demonstrated that PDW MRI had a
better uterus-tandem contrast compared to the standard
T2W MRI and therefore could be used optionally to
assist tandem delineation. The good uterus-tandem
contrast provided by PDW MRI is complementary to
the good tumor-tissue contrast offered by T2W MRI. By
combing two images sets, it is possible to achieve both
good tumor delineation and good tandem delineation
simultaneously for cervical cancer patients treated with
HDR brachytherapy.
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